Navigation Links
MedTrust Online Surpasses 5,000 Registered Users and Adds Dr. Henry Friedman to Oncology Advisory Board
Date:9/17/2009

SCOTTSDALE, Ariz., Sept. 17 /PRNewswire/ -- MedTrust Online, a world-leading provider of clinically-useful knowledge for oncologists seeking therapy options for challenging patient cancer cases, has surpassed 5,000 registered users on its free portal, Oncocentric.com. MedTrust Online also announced today that world-renowned oncologist Dr. Henry Friedman has joined MedTrust Online's growing board of oncology advisors.

"5,000 users is concrete validation that our portal can answer the critical need of oncologists for the latest medical knowledge," stated President and CEO Chris Yoo, Ph.D. "And we are honored to have Dr. Friedman join our illustrious oncology advisory board. The rapid growth in our network of users is a direct result of having the top experts available to help practicing oncologists every day through our portal."

With the addition of Dr. Henry Friedman, Deputy Director of The Preston Robert Tisch Brain Tumor Center at Duke, MedTrust Online continues to attract the brightest minds in new therapeutics and world-renowned cancer care experts.

"I personally believe that targeted personalized therapy is the wave of the future and should be accessible to everyone," stated Dr. Friedman. "I am excited to join MedTrust Online and contribute to making that statement not only a possibility, but a reality."

MedTrust Online also announced a contract with Prometheus Laboratories, another leader in the promising group of companies offering molecular diagnostics in oncology.

"We are pleased to add Prometheus Laboratories as a new content provider to our portal," said Chief Business Officer Russell Clark. "Each new molecular diagnostics customer adds important content that helps our oncologists identify the most appropriate diagnostic and therapeutic options for their patients and provides our customers with important new channels into the oncology market."

About MedTrust Online:

Founded by leaders of the Translational Genomics Research Institute (TGen), MedTrust Online (MTOL) helps cancer doctors practice the most precise medicine for their patients by providing best practice knowledge about the most difficult cases. Through the portal, www.oncocentric.com, any oncologist can find important diagnostic and treatment information and communicate with experts about the best options for individualized therapy. MTOL brings together experts in Oncology, information technology, computational biology, pharmaceutical drug development, and personalized medicine to integrate and present the latest in cutting-edge cancer care. This knowledge is presented as a free resource to doctors in a comprehensive yet concise way unavailable anywhere else.


'/>"/>
SOURCE MedTrust Online
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
2. MedTrust Online and Scottsdale Clinical Research Institute at Scottsdale Healthcare Announce Collaboration to Provide Cutting Edge Technology to Improve Patient Care
3. Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician
4. Inspiring New Online Destination From Bayer Diabetes Care
5. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
6. New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix
7. MSNBC Publishes Free Online Abridgment of Biocentrism
8. Elsevier / MC Strategies Online Courses Named in the 15th Annual Communicator Awards
9. Drug Information Association Launches New 45th Annual Meeting Online
10. New Online Tutorial for DAVID
11. PharmSource Adds New Capabilities to the PharmSource ADVANTAGE Online Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017   ... Beyond Type 1, a not-for-profit advocacy and education group ... a grant from Beyond Type 1 to support ViaCyte,s ... and other insulin-requiring diabetes.  For more ... cell-derived cell replacement therapies with a focus on the ...
(Date:2/22/2017)... Feb. 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a ... of innovative biopharmaceutical products for companion animals, will host a ... a.m. ET to discuss financial results from the fourth quarter ... Interested participants and investors may access the audio webcast ... ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
(Date:2/22/2017)... Scientists propose in Nature blocking ... Gaucher and maybe other lysosomal storage diseases as a ... current therapies. An international research team led ... also included investigators from the University of Lübeck in ... 22. The study was conducted in mouse models of ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 ... Senate Judiciary Committee, Janice Kephart of Identity ... President Donald Trump,s "Executive Order: Protecting the ... (Jan. 27, 2017):  "As President Trump,s ,Travel ... Circuit has now essentially banned the travel ban, it ...
(Date:2/9/2017)... The biomass boiler market report by Transparency Market Research ... in terms of revenue (US$ Mn) based on the ... boilers has been segmented on the basis of feedstock ... based on feedstock type, has been segmented into woody ... urban residues, and others. On the basis of product ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
Breaking Biology News(10 mins):